Long-term safety and efficacy of olokizumab in patients with rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitor therapy in phase II studies
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AVES Yayincilik
2021-07-01
|
| Series: | European Journal of Rheumatology |
| Online Access: | https://www.eurjrheumatol.org/en/long-term-safety-and-efficacy-of-olokizumab-in-patients-with-rheumatoid-arthritis-and-inadequate-response-to-tumor-necrosis-factor-inhibitor-therapy-in-phase-ii-studies-133413 |
| id |
doaj-f333c31940844bd68abc7f0c2b9f4be7 |
|---|---|
| record_format |
Article |
| spelling |
doaj-f333c31940844bd68abc7f0c2b9f4be72021-10-05T10:06:59ZengAVES YayincilikEuropean Journal of Rheumatology2147-97202148-42792021-07-018312012910.5152/eurjrheum.2021.19207Long-term safety and efficacy of olokizumab in patients with rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitor therapy in phase II studiesMark C. Genovese0Patrick Durez1Roy Fleischmann2 Yoshiya Tanaka3Daniel Furst4Hisashi Yamanaka 5 Elena Korneva6Igor Vasyutin7Tsutomu Takeuchi8Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, California, USAPôle de Pathologies Rhumatismales, Institut de Recherche Expérimentale et Clinique, Cliniques Universitaires Saint-Luc, UCL, Brussels, BelgiumDepartment of Medicine, University of Texas Southwestern Medical Center and Metroplex Clinical Research Center, Dallas, Texas, USAThe First Department of Internal Medicine, University of Occupational and Environmental Health School of Medicine, Fukuoka, JapanThe Geffen School of Medicine, University of California, Los Angeles, California, USAInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, JapanJSC “R-Pharm”, Moscow, RussiaJSC “R-Pharm”, Moscow, RussiaDivision of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japanhttps://www.eurjrheumatol.org/en/long-term-safety-and-efficacy-of-olokizumab-in-patients-with-rheumatoid-arthritis-and-inadequate-response-to-tumor-necrosis-factor-inhibitor-therapy-in-phase-ii-studies-133413 |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Mark C. Genovese Patrick Durez Roy Fleischmann Yoshiya Tanaka Daniel Furst Hisashi Yamanaka Elena Korneva Igor Vasyutin Tsutomu Takeuchi |
| spellingShingle |
Mark C. Genovese Patrick Durez Roy Fleischmann Yoshiya Tanaka Daniel Furst Hisashi Yamanaka Elena Korneva Igor Vasyutin Tsutomu Takeuchi Long-term safety and efficacy of olokizumab in patients with rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitor therapy in phase II studies European Journal of Rheumatology |
| author_facet |
Mark C. Genovese Patrick Durez Roy Fleischmann Yoshiya Tanaka Daniel Furst Hisashi Yamanaka Elena Korneva Igor Vasyutin Tsutomu Takeuchi |
| author_sort |
Mark C. Genovese |
| title |
Long-term safety and efficacy of olokizumab in patients with rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitor therapy in phase II studies |
| title_short |
Long-term safety and efficacy of olokizumab in patients with rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitor therapy in phase II studies |
| title_full |
Long-term safety and efficacy of olokizumab in patients with rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitor therapy in phase II studies |
| title_fullStr |
Long-term safety and efficacy of olokizumab in patients with rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitor therapy in phase II studies |
| title_full_unstemmed |
Long-term safety and efficacy of olokizumab in patients with rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitor therapy in phase II studies |
| title_sort |
long-term safety and efficacy of olokizumab in patients with rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitor therapy in phase ii studies |
| publisher |
AVES Yayincilik |
| series |
European Journal of Rheumatology |
| issn |
2147-9720 2148-4279 |
| publishDate |
2021-07-01 |
| url |
https://www.eurjrheumatol.org/en/long-term-safety-and-efficacy-of-olokizumab-in-patients-with-rheumatoid-arthritis-and-inadequate-response-to-tumor-necrosis-factor-inhibitor-therapy-in-phase-ii-studies-133413 |
| work_keys_str_mv |
AT markcgenovese longtermsafetyandefficacyofolokizumabinpatientswithrheumatoidarthritisandinadequateresponsetotumornecrosisfactorinhibitortherapyinphaseiistudies AT patrickdurez longtermsafetyandefficacyofolokizumabinpatientswithrheumatoidarthritisandinadequateresponsetotumornecrosisfactorinhibitortherapyinphaseiistudies AT royfleischmann longtermsafetyandefficacyofolokizumabinpatientswithrheumatoidarthritisandinadequateresponsetotumornecrosisfactorinhibitortherapyinphaseiistudies AT yoshiyatanaka longtermsafetyandefficacyofolokizumabinpatientswithrheumatoidarthritisandinadequateresponsetotumornecrosisfactorinhibitortherapyinphaseiistudies AT danielfurst longtermsafetyandefficacyofolokizumabinpatientswithrheumatoidarthritisandinadequateresponsetotumornecrosisfactorinhibitortherapyinphaseiistudies AT hisashiyamanaka longtermsafetyandefficacyofolokizumabinpatientswithrheumatoidarthritisandinadequateresponsetotumornecrosisfactorinhibitortherapyinphaseiistudies AT elenakorneva longtermsafetyandefficacyofolokizumabinpatientswithrheumatoidarthritisandinadequateresponsetotumornecrosisfactorinhibitortherapyinphaseiistudies AT igorvasyutin longtermsafetyandefficacyofolokizumabinpatientswithrheumatoidarthritisandinadequateresponsetotumornecrosisfactorinhibitortherapyinphaseiistudies AT tsutomutakeuchi longtermsafetyandefficacyofolokizumabinpatientswithrheumatoidarthritisandinadequateresponsetotumornecrosisfactorinhibitortherapyinphaseiistudies |
| _version_ |
1716843382708371456 |